bioRxivImmunologyPreprint
Pairwise Interactions in Adjuvant Combinations Dictate Immune Responses and Inform Cancer Immunotherapy Design
Surya Pandey, Adam Gruenbaum, Tamara Kashanova, Philipp Mertins, Philippe Cluzel, Nicolas Chevrier
Abstract
The immune system makes decisions in response to complex combinations of microbial inputs. We do not understand the combinatorial logic that governs how the interplay between higher-order combinations of microbial or adjuvant signals shape immune responses, which hampers the rational design of vaccines and immunotherapies. Here, using in vitro coculture experiments and statistical analyses, we discover a general property for the combinatorial sensing of microbial signals, whereby the effects of triplet combinations of adjuvants on immune responses can be explained by the effects of single and pairwise stimulations. Mechanistically, we find that adjuvant singles and pairs dictate the information signaled by triplets in mouse and human DCs at the levels of transcription, chromatin and protein secretion. Furthermore, we exploit this simplifying property to develop and characterize cell-based immunotherapies using adjuvant combinations with anti-tumor properties in mouse models. We conclude that the processing of complex mixtures of microbial or adjuvant inputs by immune cells is governed by pairwise effects, which will inform the rationale combination of immunomodulatory agents such as adjuvants to manipulate immunity.
- organism: mouse
- organism: human
- assay: bulk RNA-seq
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Programming Multifaceted Pulmonary T-Cell Immunity by Combination Adjuvants
M Suresh, Chandranaik Marinaik, … Yoshihiro Kawaoka·bioRxiv·Jul 10, 2020
- TRAF6-IRF5 kinetics, TRIF, and biophysical factors drive synergistic innate responses to particle-mediated MPLA-CpG co-presentation
P. Pradhan, R. Toy, … K. Roy·bioRxiv·Jul 17, 2020
- TLR7 and RIG-I dual-adjuvant loaded nanoparticles drive broadened and synergistic responses in dendritic cells in vitro and generate unique cellular immune responses in influenza vaccination
R. Toy, M. C. Keenum, … K. Roy·bioRxiv·Jul 17, 2020
- The PD-L1 and TLR7 dual-targeting nanobody-drug conjugate exerts potent antitumor efficacy by orchestrating innate and adaptive immune responses
- Chemotherapy synergizes with cancer vaccines and expands stem-like TCF1+CD8+ T cells
L. Noblecourt, A. Wicki, … C. S. K. Leung·bioRxiv·Dec 18, 2023
- Mechanisms regulating combination effect of antibody-drug conjugates and cancer immunotherapy
Şehmus Tohumeken, Ali Mostafa, … Dmitry I. Gabrilovich·bioRxiv·Jul 22, 2026